Ch 8 Page 4 / 25
Cancer
radiotherapy
Notions in radiobiology

Survival curves

The radiosensitivity of healthy cells or tumour cells can be determined by the preparation of survival curves after irradiation, and for cancer cells, at best using in vitro clonogenic culture (study of stem cells).

The curve which is obtained can be transformed into a mathematical model giving the proportion of surviving cells after irradiation. The mathematical model which correlates at best with the experimental curves for mammalian cells is a linear quadratic model, or ballistic model:

S = e(-αD - βD²)

where S is the survival at the dose D and α and β are two coefficients. In semilogarithmic coordinates, the curve is biphasic with an initial linear portion, then a shoulder, then a distal linear portion.

Thanks to modelling of survival curves, it is possible to formulate various hypotheses concerning the cell death induced by ionising radiation. According to this linear quadratic model, cell death can be in relation to:

Various parameters can be calculated from this equation to characterise radiosensitivity: the SF2 (Survival Fraction at 2 Gy) is most frequently is used. The greater the SF2 value, the less sensitive the cell line is to radiotherapy.

Variations in the radiosensitivity

Radiosensitivity varies from one cell line to another; haematopoietic stem cells and germinal stem cells are among the most radiosensitive. In general, the poorer a cell’s differentiation, the more radiosensitive it is.

For the same cell line, radiosensitivity varies according to:

Cell characteristics

Parameters in relation with the irradiation technique

The in vitro determination of SF2 or of D0 (the prolongation of the distal slope of the survival curve) does not systematically predict in vivo radiosensitivity, i.e. cure by radiation. In reality the D0 of tumour cell lines is not very different from the D0 of normal fibroblasts and the in vitro radiosensitivity of tumour cells from an in vivo non sensitive tumour is similar to the sensitivity of cells issued from radiocurable tumours.

Many hypotheses have been formulated concerning this discrepancy between in vitro radiosensitivity and in vivo radiocurability:

Cancer Radiotherapy - You are looking at www.oncoprof.net website